Yara International (YAR) Q4 2021 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2021 earnings summary
28 Oct, 2026Executive summary
2021 underlying performance strengthened: EBITDA excluding special items rose 34% YoY as higher product prices more than offset higher energy and fixed costs. Net income fell amid impairment charges.
Strategy centers on operational excellence and expanding commercial offerings, with a new ambition to grow a nature-positive food future and pursue climate neutrality by 2050.
Financial highlights
Revenue and other income rose 42% to $16.607B; reported EBITDA was $2.804B vs. $2.223B, while adjusted EBITDA excluding special items was $2.891B vs. $2.161B.
Operating income was $1.068B vs. $1.176B; net income attributable to parent shareholders was $384M vs. $691M.
Basic EPS was $1.75 vs. $2.58; adjusted EPS excluding currency and special items was $4.73 vs. $3.08.
Net cash from operations was $1.406B vs. $2.047B; net interest-bearing debt ended at $3.930B, up from $2.930B.
Outlook and guidance
2022 investment expected at $1.5B, including $0.4B of phasing from 2021; average annual investment excluding phasing capped at $1.2B from 2022.
Targets include ROIC above 10% mid-cycle, scope 1 and 2 emissions down 30% by 2030 from 2019, and climate neutrality by 2050.
New business models target incremental EBITDA of $300–600M by 2025; 2025 targets include $1.5B revenue from new business models and $1.2B from online sales.
Market outlook was supportive entering 2022, with robust nitrogen demand, tight supply and low global inventories at year-end 2021; new nitrogen projects were projected to increase in 2022.
Latest events from Yara International
- Q4 EBITDA fell 46% YoY, while stronger margins and buying pointed to possible H1 volume catch-up.YAR
Q4 2023 - Record profitability and 25.7% ROIC amid supply shocks and strategic clean-ammonia investment.YAR
Q4 2022 - Higher operating income and cash flow offset weaker commodity prices in FY20.YAR
Q4 2020 - Adjusted EBITDA rose 42%, but ROIC remained below the >10% through-cycle target.YAR
Q4 2019 - EBITDA rose 13%, but currency losses cut net income to USD 159 million.YAR
Q4 2018 - Q4 earnings improved, but higher costs weakened FY results despite program progress.YAR
Q4 2017 - Q4 adjusted EBITDA rose 15%, but FY adjusted EBITDA fell 18%.YAR
Q4 & CMD 2017 - Q3 adjusted EBITDA fell 16% amid higher gas costs, while L12M ROIC reached 13.5%.YAR
Q3 2026 - Q4 EBITDA rose 37% to $709M as European CBAM buying and tight nitrogen markets shaped the outlook.YAR
Q4 2025